Literature DB >> 24454091

4-Benzyl-sulfanyl-1H-pyrazolo-[3,4-d]pyrimidine.

Mohammed El Fal1, Youssef Ramli2, El Mokhtar Essassi1, Mohamed Saadi3, Lahcen El Ammari3.   

Abstract

The pyrazolo-[3,4-d]pyrimidine ring system of the title compound, C12H10N4S, is essentially planar [maximum deviation = 0.025 (1) Å for the C atom bearing the S atom] and almost perpendicular to the phenyl ring [dihedral angle = 71.42 (6)°]. In the crystal, mol-ecules are linked via pairs of N-H⋯N hydrogen bonds, forming inversion dimers.

Entities:  

Year:  2013        PMID: 24454091      PMCID: PMC3884315          DOI: 10.1107/S160053681302789X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological properties of pyrazolo­[3,4-d]pyrimidine derivatives, see: Rashad et al. (2008 ▶, 2011 ▶); Ballell et al. (2007 ▶). For related compounds, see: Moussaif et al. (2010 ▶); Ouzidan et al. (2011 ▶); Alsubari et al. (2011 ▶).

Experimental

Crystal data

C12H10N4S M = 242.30 Monoclinic, a = 9.4737 (3) Å b = 5.1709 (2) Å c = 23.6159 (8) Å β = 96.823 (1)° V = 1148.69 (7) Å3 Z = 4 Mo Kα radiation μ = 0.26 mm−1 T = 296 K 0.42 × 0.29 × 0.17 mm

Data collection

Bruker X8 APEXII diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.960, T max = 0.991 15333 measured reflections 3509 independent reflections 2885 reflections with I > 2σ(I) R int = 0.029

Refinement

R[F 2 > 2σ(F 2)] = 0.041 wR(F 2) = 0.112 S = 1.03 3509 reflections 154 parameters H-atom parameters constrained Δρmax = 0.37 e Å−3 Δρmin = −0.23 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012 ▶); software used to prepare material for publication: PLATON (Spek, 2009 ▶) and publCIF (Westrip, 2010 ▶). Crystal structure: contains datablock(s) I. DOI: 10.1107/S160053681302789X/rz5086sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S160053681302789X/rz5086Isup2.hkl Click here for additional data file. Supplementary material file. DOI: 10.1107/S160053681302789X/rz5086Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C12H10N4SF(000) = 504
Mr = 242.30Dx = 1.401 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 3509 reflections
a = 9.4737 (3) Åθ = 2.6–30.5°
b = 5.1709 (2) ŵ = 0.26 mm1
c = 23.6159 (8) ÅT = 296 K
β = 96.823 (1)°Sheet, yellow
V = 1148.69 (7) Å30.42 × 0.29 × 0.17 mm
Z = 4
Bruker X8 APEXII diffractometer3509 independent reflections
Radiation source: fine-focus sealed tube2885 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.029
φ and ω scansθmax = 30.5°, θmin = 2.6°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −13→12
Tmin = 0.960, Tmax = 0.991k = −7→7
15333 measured reflectionsl = −33→33
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.041Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.112H-atom parameters constrained
S = 1.03w = 1/[σ2(Fo2) + (0.0573P)2 + 0.2818P] where P = (Fo2 + 2Fc2)/3
3509 reflections(Δ/σ)max = 0.001
154 parametersΔρmax = 0.37 e Å3
0 restraintsΔρmin = −0.23 e Å3
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.
Refinement. Refinement of F2 against all reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on all data will be even larger.
xyzUiso*/Ueq
C10.53146 (14)0.5891 (3)0.39990 (6)0.0400 (3)
H10.61860.60930.38600.048*
C20.38176 (14)0.7002 (2)0.46100 (5)0.0347 (3)
C30.17220 (16)0.5324 (3)0.47363 (7)0.0510 (4)
H30.09140.42890.46980.061*
C40.28477 (13)0.5093 (2)0.43999 (5)0.0349 (3)
C50.32168 (12)0.3638 (2)0.39401 (5)0.0315 (2)
C60.28394 (15)0.0099 (3)0.30385 (6)0.0416 (3)
H6A0.38630.01570.31340.050*
H6B0.2568−0.16990.29790.050*
C70.24460 (14)0.1560 (2)0.24936 (6)0.0369 (3)
C80.12518 (16)0.0842 (3)0.21266 (6)0.0467 (3)
H80.0701−0.05510.22190.056*
C90.08797 (17)0.2192 (4)0.16251 (7)0.0555 (4)
H90.00860.16830.13800.067*
C100.16673 (19)0.4269 (4)0.14851 (7)0.0566 (4)
H100.14020.51830.11500.068*
C110.28603 (18)0.4997 (3)0.18457 (7)0.0534 (4)
H110.34010.64000.17520.064*
C120.32523 (16)0.3646 (3)0.23458 (6)0.0450 (3)
H120.40600.41360.25840.054*
N10.44627 (11)0.4023 (2)0.37454 (5)0.0371 (2)
N20.50762 (11)0.7469 (2)0.44184 (5)0.0385 (2)
N30.32520 (13)0.8224 (2)0.50327 (5)0.0456 (3)
H3N0.36510.94870.52270.055*
N40.19642 (15)0.7201 (3)0.51134 (6)0.0583 (4)
S10.20019 (4)0.13646 (7)0.363530 (14)0.04065 (11)
U11U22U33U12U13U23
C10.0380 (6)0.0415 (7)0.0407 (7)−0.0091 (5)0.0060 (5)−0.0020 (5)
C20.0405 (6)0.0316 (6)0.0305 (5)−0.0006 (5)−0.0017 (4)−0.0004 (4)
C30.0425 (7)0.0646 (10)0.0478 (8)−0.0093 (7)0.0126 (6)−0.0170 (7)
C40.0351 (6)0.0369 (6)0.0321 (6)−0.0032 (5)0.0020 (4)−0.0023 (5)
C50.0335 (6)0.0297 (5)0.0301 (5)−0.0011 (4)−0.0007 (4)0.0009 (4)
C60.0476 (7)0.0327 (6)0.0432 (7)0.0040 (5)−0.0008 (5)−0.0070 (5)
C70.0396 (6)0.0322 (6)0.0388 (6)0.0053 (5)0.0044 (5)−0.0080 (5)
C80.0434 (7)0.0441 (7)0.0506 (8)0.0005 (6)−0.0025 (6)−0.0039 (6)
C90.0476 (8)0.0655 (10)0.0505 (8)0.0123 (8)−0.0060 (6)−0.0025 (8)
C100.0608 (9)0.0641 (10)0.0464 (8)0.0263 (8)0.0126 (7)0.0104 (7)
C110.0598 (9)0.0468 (8)0.0576 (9)0.0059 (7)0.0231 (7)0.0055 (7)
C120.0445 (7)0.0435 (8)0.0480 (8)−0.0009 (6)0.0091 (6)−0.0068 (6)
N10.0368 (5)0.0373 (6)0.0373 (5)−0.0044 (4)0.0050 (4)−0.0037 (4)
N20.0421 (6)0.0349 (6)0.0377 (5)−0.0080 (5)0.0008 (4)−0.0010 (4)
N30.0506 (7)0.0457 (6)0.0401 (6)−0.0053 (5)0.0040 (5)−0.0130 (5)
N40.0521 (7)0.0715 (9)0.0535 (8)−0.0077 (7)0.0158 (6)−0.0225 (7)
S10.03936 (18)0.0419 (2)0.04027 (18)−0.01091 (13)0.00279 (12)−0.00697 (13)
C1—N21.3234 (17)C6—H6B0.9700
C1—N11.3521 (17)C7—C121.390 (2)
C1—H10.9300C7—C81.3914 (19)
C2—N31.3455 (17)C8—C91.384 (2)
C2—N21.3464 (17)C8—H80.9300
C2—C41.3988 (17)C9—C101.371 (3)
C3—N41.319 (2)C9—H90.9300
C3—C41.4085 (19)C10—C111.384 (3)
C3—H30.9300C10—H100.9300
C4—C51.3992 (17)C11—C121.385 (2)
C5—N11.3316 (16)C11—H110.9300
C5—S11.7399 (12)C12—H120.9300
C6—C71.5008 (19)N3—N41.3637 (18)
C6—S11.8193 (14)N3—H3N0.8600
C6—H6A0.9700
N2—C1—N1128.77 (12)C8—C7—C6120.02 (13)
N2—C1—H1115.6C9—C8—C7120.27 (15)
N1—C1—H1115.6C9—C8—H8119.9
N3—C2—N2127.71 (12)C7—C8—H8119.9
N3—C2—C4106.97 (12)C10—C9—C8120.74 (15)
N2—C2—C4125.32 (12)C10—C9—H9119.6
N4—C3—C4111.15 (13)C8—C9—H9119.6
N4—C3—H3124.4C9—C10—C11119.54 (15)
C4—C3—H3124.4C9—C10—H10120.2
C2—C4—C5116.14 (11)C11—C10—H10120.2
C2—C4—C3104.44 (11)C10—C11—C12120.27 (16)
C5—C4—C3139.39 (12)C10—C11—H11119.9
N1—C5—C4120.07 (11)C12—C11—H11119.9
N1—C5—S1121.88 (9)C11—C12—C7120.41 (14)
C4—C5—S1118.05 (9)C11—C12—H12119.8
C7—C6—S1113.35 (9)C7—C12—H12119.8
C7—C6—H6A108.9C5—N1—C1117.44 (11)
S1—C6—H6A108.9C1—N2—C2112.17 (11)
C7—C6—H6B108.9C2—N3—N4111.31 (12)
S1—C6—H6B108.9C2—N3—H3N124.3
H6A—C6—H6B107.7N4—N3—H3N124.3
C12—C7—C8118.76 (14)C3—N4—N3106.12 (12)
C12—C7—C6121.21 (12)C5—S1—C6103.63 (6)
N3—C2—C4—C5178.01 (11)C10—C11—C12—C7−0.6 (2)
N2—C2—C4—C5−2.39 (19)C8—C7—C12—C110.8 (2)
N3—C2—C4—C3−0.53 (15)C6—C7—C12—C11−178.96 (13)
N2—C2—C4—C3179.08 (13)C4—C5—N1—C1−1.62 (18)
N4—C3—C4—C20.49 (18)S1—C5—N1—C1177.92 (10)
N4—C3—C4—C5−177.49 (16)N2—C1—N1—C5−1.3 (2)
C2—C4—C5—N13.22 (17)N1—C1—N2—C22.1 (2)
C3—C4—C5—N1−178.96 (17)N3—C2—N2—C1179.40 (13)
C2—C4—C5—S1−176.34 (9)C4—C2—N2—C1−0.13 (18)
C3—C4—C5—S11.5 (2)N2—C2—N3—N4−179.18 (13)
S1—C6—C7—C1290.97 (14)C4—C2—N3—N40.42 (16)
S1—C6—C7—C8−88.78 (14)C4—C3—N4—N3−0.2 (2)
C12—C7—C8—C9−0.1 (2)C2—N3—N4—C3−0.11 (19)
C6—C7—C8—C9179.65 (13)N1—C5—S1—C6−3.06 (12)
C7—C8—C9—C10−0.8 (2)C4—C5—S1—C6176.49 (10)
C8—C9—C10—C111.0 (2)C7—C6—S1—C5−90.38 (11)
C9—C10—C11—C12−0.3 (2)
D—H···AD—HH···AD···AD—H···A
N3—H3N···N2i0.862.102.9429 (16)168
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
N3—H3N⋯N2i 0.862.102.9429 (16)168

Symmetry code: (i) .

  8 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Synthesis and anticancer effects of some novel pyrazolo[3,4-d]pyrimidine derivatives by generating reactive oxygen species in human breast adenocarcinoma cells.

Authors:  Aymn E Rashad; Abeer E Mahmoud; Mamdouh M Ali
Journal:  Eur J Med Chem       Date:  2011-01-15       Impact factor: 6.514

3.  Synthesis and antiviral evaluation of some new pyrazole and fused pyrazolopyrimidine derivatives.

Authors:  Aymn E Rashad; Mohamed I Hegab; Randa E Abdel-Megeid; Jehan A Micky; Farouk M E Abdel-Megeid
Journal:  Bioorg Med Chem       Date:  2008-07-02       Impact factor: 3.641

4.  New thiopyrazolo[3,4-d]pyrimidine derivatives as anti-mycobacterial agents.

Authors:  Lluis Ballell; Robert A Field; Gavin A C Chung; Robert J Young
Journal:  Bioorg Med Chem Lett       Date:  2006-12-22       Impact factor: 2.823

5.  3-[2-(1H-Benzimidazol-2-ylsulfan-yl)eth-yl]-1,3-oxazolidin-2-one.

Authors:  Ahmed Moussaif; El Mokhtar Essassi; Said Lazar; Hafid Zouihri; Jean Michel Leger
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-13

6.  1-Benzyl-1H-benzimidazol-2(3H)-one.

Authors:  Younes Ouzidan; El Mokhtar Essassi; Santiago V Luis; Michael Bolte; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-25

7.  5-(Pyridin-4-ylmeth-yl)-1H-pyrazolo-[3,4-d]pyrimidin-4(5H)-one.

Authors:  Abdulsalam Alsubari; Youssef Ramli; El Mokhtar Essassi; Hafid Zouihri
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-07-06

8.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  8 in total
  4 in total

1.  Crystal structure of 1-methyl-4-methyl-sulfanyl-1H-pyrazolo-[3,4-d]pyrimidine.

Authors:  Mohammed El Fal; Youssef Ramli; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-11-21

2.  The crystal structure of 1,5-dibenzyl-1H-pyrazolo-[3,4-d]pyrimidine-4(5H)-thione.

Authors:  Mohammed El Fal; Youssef Ramli; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-10

3.  Crystal structure of 4-allyl-sulfanyl-1H-pyrazolo-[3,4-d]pyrimidine.

Authors:  Mohammed El Fal; Youssef Ramli; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-08-23

4.  Crystal structure of 1-ethyl-pyrazolo[3,4-d]pyrimidine-4(5H)-thione.

Authors:  Mohammed El Fal; Youssef Ramli; El Mokhtar Essassi; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-08-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.